What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Kwang Hyub Han spends much of his time researching Internal medicine, Gastroenterology, Hepatocellular carcinoma, Cirrhosis and Hepatitis B.
His Internal medicine research is multidisciplinary, incorporating perspectives in Entecavir, HBeAg and Surgery.
Kwang Hyub Han has included themes like Fibrosis, Pathology, Liver biopsy and Hepatitis B virus in his Gastroenterology study.
Kwang Hyub Han has researched Hepatocellular carcinoma in several fields, including Carcinoma, Radiology and Hazard ratio.
His Cirrhosis research includes elements of Stage and Predictive value of tests.
His biological study deals with issues like Hepatitis C, which deal with fields such as Epidemiology.
His most cited work include:
- A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B (1212 citations)
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial (1199 citations)
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. (843 citations)
What are the main themes of his work throughout his whole career to date?
Kwang Hyub Han mainly focuses on Internal medicine, Gastroenterology, Hepatocellular carcinoma, Cirrhosis and Hepatitis B virus.
The various areas that he examines in his Internal medicine study include Surgery and Oncology.
His work deals with themes such as Chronic hepatitis, Liver biopsy, Hazard ratio, Entecavir and Fibrosis, which intersect with Gastroenterology.
His work carried out in the field of Hepatocellular carcinoma brings together such families of science as Radiology, Radiation therapy, Carcinoma and Retrospective cohort study.
His Cirrhosis study incorporates themes from Receiver operating characteristic, Liver disease, Ascites and Pathology.
His Transient elastography research incorporates elements of Liver stiffness and Confidence interval.
He most often published in these fields:
- Internal medicine (66.41%)
- Gastroenterology (51.04%)
- Hepatocellular carcinoma (47.14%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (66.41%)
- Hepatocellular carcinoma (47.14%)
- Gastroenterology (51.04%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Hepatocellular carcinoma, Gastroenterology, In patient and Cirrhosis.
His Internal medicine research integrates issues from Entecavir, Chronic hepatitis and Hepatitis B virus.
His research integrates issues of Radiology, Radiation therapy, Carcinoma and Oncology in his study of Hepatocellular carcinoma.
The study incorporates disciplines such as Hepatitis B, Population study, Multivariate analysis, Antiviral therapy and Fibrosis in addition to Gastroenterology.
The Hepatitis B study which covers Univariate analysis that intersects with Steatosis.
His Cirrhosis study also includes
- Hepatitis C most often made with reference to Hepatitis C virus,
- Disease most often made with reference to Liver disease.
Between 2018 and 2021, his most popular works were:
- A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea (57 citations)
- Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. (43 citations)
- Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma. (27 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of investigation include Hepatocellular carcinoma, Internal medicine, Gastroenterology, Entecavir and Hazard ratio.
His biological study spans a wide range of topics, including Carcinoma, Radiology, Overall survival and Cohort.
The concepts of his Internal medicine study are interwoven with issues in Oncology and Hepatitis B virus.
His Gastroenterology research is multidisciplinary, relying on both Hepatitis B, External validation and Incidence, Cumulative incidence.
Kwang Hyub Han usually deals with Hepatitis B and limits it to topics linked to Univariate analysis and Magnetic resonance imaging and Hyperintensity.
His study in the field of Hepatic fibrosis also crosses realms of Hepatocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
